Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.

Lopez, Sebastien; Turle-Lorenzo, Nathalie; Acher, Francine; De Leonibus, Elvira; Mele, Andrea; Amalric, Marianne

Lopez, Sebastien; Turle-Lorenzo, Nathalie; Acher, Francine; De Leonibus, Elvira; Mele, Andrea; Amalric, Marianne.

Affiliation

Lopez S; Laboratoire de Neurobiologie de la Cognition, Aix-Marseille Université, Centre National de la Recherche Scientifique Unité Mixte de Recherche 6155, 13331 Marseille, France.

J Neurosci ; 27(25): 6701-11, 2007 Jun 20.

Article in En | MEDLINE | ID: mdl-17581957

Subject(s)

Disease Models, Animal; Drug Delivery Systems; Parkinson Disease/metabolism; Reaction Time/physiology; Receptors, Metabotropic Glutamate/metabolism; Animals; Catalepsy/chemically induced; Catalepsy/metabolism; Drug Delivery Systems/methods; Excitatory Amino Acid Agonists/administration & dosage; Excitatory Amino Acid Antagonists/administration & dosage; Male; Parkinson Disease/drug therapy; Rats; Rats, Wistar; Reaction Time/drug effects; Receptors, Metabotropic Glutamate/agonists; Receptors, Metabotropic Glutamate/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Reaction Time / Drug Delivery Systems / Receptors, Metabotropic Glutamate / Disease Models, Animal Limits: Animals Language: En Journal: J Neurosci Year: 2007 Document type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google